Literature DB >> 2024489

Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA.

J Kamine1, P Loewenstein, M Green.   

Abstract

We have utilized a gel retardation assay to study the binding of chemically synthesized domains of the HIV-1 Tat protein to radiolabeled trans-activating response element (Tar) RNA. As with recombinant Tat protein, synthetic Tat specifically binds to Tar RNA and not to a defective Tar RNA or to anti-sense Tar RNA. The 6 amino acid portion of the basic region containing five arginines is sufficient to confer Tar binding to overlapping Tat protein fragments; Tat fragments that lack the basic region do not bind Tar. In addition, the basic region alone can also bind Tar RNA; however, binding of the basic region is non specific since defective Tar RNA is bound as well as wild type Tar RNA. Binding specificity for wild type Tar RNA can be conferred by the addition of a minimum of 8 random amino acids to either end of the basic region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024489     DOI: 10.1016/0042-6822(91)90598-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.

Authors:  E P Loret; P Georgel; W C Johnson; P S Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

2.  Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter.

Authors:  K Desai; P M Loewenstein; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus.

Authors:  D W Hoffman; S W White
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

4.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.

Authors:  S J Madore; B R Cullen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Bidirectional effectors of a group I intron ribozyme.

Authors:  Y Liu; M J Leibowitz
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

6.  Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen.

Authors:  A Gatignol; C Buckler; K T Jeang
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).

Authors:  D P Siderovski; T Matsuyama; E Frigerio; S Chui; X Min; H Erfle; M Sumner-Smith; R W Barnett; T W Mak
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

8.  Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.

Authors:  J Kamine; T Subramanian; G Chinnadurai
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

Authors:  L Steinaa; A M Sørensen; J O Nielsen; J E Hansen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.

Authors:  J Kamine; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.